►
From YouTube: COVID Vaccine in Arlington
Description
No description was provided for this meeting.
If this is YOUR meeting, an easy way to fix this is to add a description to your video, wherever mtngs.io found it (probably YouTube).
A
So
I'm
gonna
talk
about
the
special
populations
being
tested,
because
I
know
that
sometimes
is
something
that
people
want
to
know
about
so
based
on
the
public
information,
and
this
will
be
confirmed
when
the
fda
does
its
reviews-
non-pregnant
adults,
ages,
18
years
and
older,
to
include
these
specific
segments
of
society.
A
The
elderly
and
those
who
are
racially
ethnic.
Minority
groups
are
supposed
to
be
part
of
these
these
trials.
I
don't
have
any
specifics
on
that.
That
is
what
we're
waiting
for
the
fda
review
and
seeing
if
they
believe,
there's
enough
data.
These
reviews
should
provide
more
information,
so
stay
tuned
groups
to
be
included
in
future
studies,
children.
I
know
this
is
going
to
surprise
people,
but
this
has
been
a
usual
practices.
A
That's
these
types
of
studies
are
typically
done
after
it's
proven
that
the
vaccine
is
safe
and
effective
in
adults,
because
the
value
has
been
that
we
are
going
to
protect
our
most
fragile
in
society
like
children,
especially
if
they're
not
at
the
greatest
risk.
Initially,
it
makes
sense,
but
I
know
people
are
going
to
be
disturbed
that
it
wasn't
done
at
the
same
time.
But
this
is
the
standard
processes
for
vaccines
and
pregnant
women
have
not
been
excuse
me
enrolled
initially.
A
However,
having
said
those
studies
will
happen,
but
obviously
they
don't
know
when
people
enroll
in
these
studies,
men
and
women,
if
the
those
who
are
able
to
get
pregnant
actually
become
pregnant
during
that
time
frame.
So
they
may
have
some
data,
but
I'm
not
promising
it.
Yet.
So
that's
what
I'm
looking
for
and
my
colleagues
at
the
state
level
are
looking
for
and
in
the
region.
What
is
the
real
information
about?
What
is
known
and
not
known
from
these
studies
and
we're
talking?
A
So
so,
where
do
we
stand
with
vaccine
in
in
virginia
and
arlington?
A
So
some
of
you
know
that
the
advisory
committee
on
immunization
practices
a
prioritization
meeting
early
on
december
1st
2020,
and
they
basically
decided
to
agree
with
the
recommendations
from
the
national
academy
of
sciences
about
prioritizing
healthcare,
personnel
and
long-term
care
facility
residents,
and
that
fits
with
their
principles
and
they're
published.
A
So
I'm
not
gonna
review
those,
but
healthcare
personnel
as
they
defined
it
are
paid
and
unpaid
persons
serving
in
health
care
settings
who
have
the
potential
for
direct
or
indirect
exposure
to
patients
or
infectious
materials,
and
that
includes
long-term
care
facility
staff
and
then
the
long-term
care
facility
residents
are
defined
as
adults
who
reside
in
facilities
that
provide
a
variety
of
services,
including
medical
and
personnel
care.
Sorry,
personal
care
to
persons
who
are
unable
to
live
independently
and
that
committee's
recommendations
had
to
be
approved
by
the
cdc
director,
and
it
has
been
done.
A
As
I've
mentioned,
the
fda
is
having
meetings
to
review
the
emergency
use
authorization
requests
december.
10Th
is
the
pfizer
review
for
its
messenger,
rna,
vaccine
and
moderna
it's
december
17th,
also
for
its
messenger
rna
vaccine
and
then,
after
those
approvals,
the
acip
is
supposed
to
meet
again.
A
So
if
fda
approves,
what
are
these
vaccines?
What
are
the
next
steps
in
virginia
and
arlington?
I
want
to
remind
everyone
that
arlington
county
public
health
division
has
another
name.
It's
the
arlington
health
district,
we're
one
of
the
35
health
districts
in
virginia
under
the
virginia
department
of
health.
So
we
are
going
to
have
the
same
access,
obviously
based
on
whatever
our
personal
characteristics
are
make
up
of
those
populations,
and
they
want
to
remind
people.
A
The
reason
why
we're
vaccinating
is
because
of
the
very
potential
of
the
pandemic,
as
we've
seen
it
in
this
rise
virginia,
is
preparing
to
receive
a
total
estimated
480
000
doses
of
vaccine
from
the
two
manufacturers.
If
they
are
approved,
I
don't
have
the
specific
ratios
at
this
time
and
as
a
reminder
to
everyone.
A
The
actual
amount
received
is
a
moving
target
and,
depending
on
vaccine,
manufacture,
output,
but
we're
getting
more
confident,
that's
roughly
what
we
should
be
getting
that
with
the
vdh
estimate
that
there
are
up
to
500
000
healthcare
personnel,
including
the
staff
at
long-term
care
facilities,
as
well
as
the
long-term
care
facility
residents
in
virginia
means
that
we
should
be
able
to
vaccinate
the
majority
of
those
categories
if
all
goes
well
with
their
first
dose
of
vaccine
in
december
and
january,
when
this
stuff
all
happens.
The
devil,
of
course,
is
in
the
details.
A
Vdh
is
working
with
the
virginia
hospital
and
healthcare
association
or
vha
to
prepare
the
health
systems
that
have
the
ultra
cold
chain
storage
ability
to
receive
these
first
shipments
because
it
has
to
be
done
safely
and
you
don't
want
to
go
through
the
expense
of
creating
all
of
this
and
then
not
maintain
the
vaccine
at
the
appropriate
temperature,
because
the
mrna
technology,
because
it's
it's
a
natural
process
in
the
cells
and
it's
not
supposed
to
last
very
long-
the
the
instructions
break
down.
A
All
of
the
initial
doses
will
be
distributed
to
various
health
care
systems
with
that
capacity,
and
the
plan
is
that
those
health
care
personnel
that
directly
care
for
covet,
19
patients
or
in
support
of
that,
will
receive
top
priority.
First,
let
me
see
what
next
we
expect.
The
second
doses
at
the
appropriate
time
for
these
vaccines.
A
So
if
you
have
dose
on
day
one
or
day
zero,
sorry,
then
one
of
the
vaccines
requires
immunization,
again
21
days
later,
the
other
28
days
later,
and
so
we
expect,
based
on
what
we've
been
told
from
the
federal
government,
to
get
the
second
doses
at
the
appropriate
time,
and
obviously
people
have
this
question
so,
as
future
weeks
bring
more
deliveries,
we
expect
that
there
could
be
overlap
in
the
doses
being
administered.
That
is
some
getting
first
doses
and
others
second
doses.
A
In
the
same
weeks,
people
will
want
to
know
what
we
as
a
division,
health
district
in
the
county,
have
been
doing
in
broad
strokes,
while
we've
had
plans
for
years
for
mass
vaccination.
Obviously,
the
wrinkle
is
incorporating
six
foot
distances
to
those
plans
and
all
of
the
plans
here
and
elsewhere
work.
A
We
have
to
build
in
appointment
schedules
because
you
don't
want
people
to
congregate
in
lines
and
pass
germs
to
each
other,
so
this
is
something
that
all
states
and
localities
are
going
to
have
to
deal
with,
and
it's
just,
I
think
one
of
the
things
we
have
to
remember
is
this
is
part
of
current
covenant.
Reality.
A
So
a
lot
of
this
is
significant
moving
parts
and
we
need
to
have
those
things
in
place,
and
so,
as
our
county
manager
mark
schwartz
has
indicated,
we
need
to
be
prepared
for
changing
information.
I
know
our
community,
as
everyone
else
is
anxious
to
be
over
with
this,
and
we
ask
for
patience,
because
things
will
change
and
a
few
last
comments
on
vaccine
before
letting
you
ask
questions:
how
much
will
the
covet
vaccine
cost
it
well
itself?
The
vaccine
itself
will
not
cost
anyone
anything.
These
are
the
miscellaneous
points.
A
Providers
who
are
who
can
charge
to
insurance
are
allowed
to
do
that.
Vdh
is
not
gonna
charge
that
for
any
of
the
public
clinics
that
the
health
districts
run,
we
don't
want
any
barriers,
especially
for
our
at-risk
populations
and
as
a
reminder.
How
many
doses
of
covered
vaccine
will
be
needed
and
will
a
booster
dose
be
needed?
A
We
don't
know
for
sure.
Yet
we
obviously
know
how
much
how
many
doses
are
needed
for
the
vaccines
coming
out.
The
two
if
they're
approved
it
would
be
two
doses
there
is
one
that
is,
would
only
require
one.
However,
as
time
goes
on,
we
will
learn
whether
future
doses
are
needed,
like
needing
a
tetanus
shot
every
10
years.
A
Obviously
we
won't
know
that
information,
because
we've
only
had
four
or
five
months
with
the
studies
that
they've
done,
and
so
I
hope
people
will
be
reasonable
in
their
thinking
about
this,
that
we
can't
have
more
information
than
time
is
actually
allotted
for
us
with
that.
I
am
turning
it
back
to
you,
madam
chair.